Part of the Hidradenitis Suppurativa Knowledge Library
Understanding the Hormonal Dimensions of Hidradenitis Suppurativa with Ayurveda
Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by painful lumps and abscesses in areas where skin rubs together, such as the armpits, groin, and under the breasts (Jemec, 2012). While the causes of HS are complex, research suggests that hormones play a significant role in the condition, with flare-ups often linked to hormonal changes associated with puberty, menstruation, pregnancy, and menopause (Vossen et al., 2018). From an Ayurvedic perspective, hormonal imbalances disrupt the body’s doshic harmony, contributing to inflammation and skin congestion (Lad, 2002). EliteAyurveda’s approach addresses these hormonal dimensions holistically, using personalized Ayurvedic treatments to balance the doshas and support stable hormone health.
Understanding the Hormonal Dimensions of Hidradenitis Suppurativa with Ayurveda
Hormonal changes are known to impact the sebaceous glands and hair follicles, which play a central role in HS (Schäfer et al., 2011). These glands are influenced by various hormones, including androgens, estrogen, and progesterone, which can affect skin thickness, oil production, and inflammation levels (Kimball et al., 2016). Many patients report that HS symptoms worsen during hormonal shifts, such as around menstruation or pregnancy, highlighting the role of hormones in HS flare-ups (Vossen et al., 2018).
In Ayurveda, hormonal imbalances are understood through the lens of doshic balance (Lad, 2002). The primary doshas involved in HS are Pitta and Kapha, with Pitta representing the inflammatory processes and heat, while Kapha reflects congestion, fluid retention, and skin blockages (Pole, 2006). Vata, associated with movement and dryness, can also influence HS by contributing to stress, irregularity, and immune sensitivity (Frawley, 1997).
EliteAyurveda’s approach aims to stabilize these doshas, promote hormonal balance, and reduce inflammation, helping patients experience fewer symptoms and long-term relief.
To address HS from a hormonal perspective, EliteAyurveda takes a comprehensive approach that includes dietary guidance, lifestyle adjustments, personalized herbal medication, and stress management. This holistic care targets hormonal imbalances, reduces inflammation, and supports skin health through natural means.
In Ayurveda, diet is a primary means of balancing hormones and doshas, especially for chronic conditions like HS (Lad, 2002). A diet that stabilizes Pitta and Kapha helps manage inflammation, congestion, and hormonal fluctuations.
At EliteAyurveda, our practitioners provide customized Ayurvedic herbs that address both hormonal and doshic imbalances without adverse side effects (Sharma & Chandola, 2011).
In Ayurveda, a structured daily routine, or Dinacharya, is essential for supporting hormonal stability and reducing doshic aggravation (Lad, 2002).
Chronic stress elevates cortisol levels, which can disrupt hormonal balance and immune function, exacerbating HS symptoms (Prens & Deckers, 2015). Ayurveda emphasizes mind-body practices to support stress reduction and hormone stability.
Ayurveda recognizes that seasonal changes and lifestyle factors influence hormonal balance and skin health (Lad, 2002). EliteAyurveda incorporates seasonal and lifestyle adjustments to support the body’s natural rhythms and prevent HS aggravations.
The Ayurvedic approach to managing hormonal aspects of HS offers significant, long-term benefits by addressing root imbalances and promoting a balanced, resilient body (Lad, 2002). Key benefits include:
At EliteAyurveda, we offer a personalized, compassionate approach to managing the hormonal dimensions of Hidradenitis Suppurativa. Our care plans include Ayurvedic herbal medications, dietary and lifestyle guidance, and emotional support that adapt to each patient’s unique hormonal and doshic needs. By addressing HS at its roots and empowering patients with knowledge and tools for balanced health, we help reduce symptoms and improve quality of life naturally and sustainably.
If you’re seeking a holistic, natural approach to managing the hormonal aspects of Hidradenitis Suppurativa, EliteAyurveda offers the expertise, care, and personalized support to help you achieve greater comfort and balance.
Related-
Know More About Ayurveda Hidradenitis suppurative Treatment.
GET IN TOUCH
Contact us
References
1.
Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539-561. doi:10.1016/j.jaad.2008.11.911
Google Scholar
2.
Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J. What is hidradenitis suppurativa? Can Fam Physician. 2017;63(2):114-120.
Google Scholar
3.
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5):1045-1058. doi:10.1016/j.jaad.2019.08.090
Google Scholar
4.
Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatol. 2017;153(8):760-764. doi:10.1001/jamadermatol.2017.0201
Google Scholar
5.
Saunte DML, Jemec GBE. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. Jama. 2017;318(20):2019-2032. doi:10.1001/jama.2017.16691
Google Scholar
6.
Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122(6):763-769. doi:10.1111/j.1365-2133.1990.tb06264.x
Google Scholar
7.
Kelly G, Prens EP. Inflammatory Mechanisms in Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):51-58. doi:10.1016/j.det.2015.08.004
Google Scholar
8.
Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76-90. doi:10.1016/j.jaad.2019.02.067
Google Scholar
9.
Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91-101. doi:10.1016/j.jaad.2019.02.068
Google Scholar
10.
Deckers IE, Janse IC, van der Zee HH, et al. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol. 2016;75(4):755-759.e1. doi:10.1016/j.jaad.2016.04.067
Google Scholar
11.
Delany E, Gormley G, Hughes R, et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32(3):467-473. doi:10.1111/jdv.14686
Google Scholar
12.
Gasparic J, Theut Riis P, Jemec GB. Recognizing syndromic hidradenitis suppurativa: a review of the literature. J Eur Acad Dermatol Venereol. 2017;31(11):1809-1816. doi:10.1111/jdv.14464
Google Scholar
13.
Price KN, Thompson AM, Rizvi O, et al. Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa. Jama Dermatology. 2020;156(3):345-348. doi:10.1001/jamadermatol.2019.4595
Google Scholar
14.
Price KN, Collier EK, Grogan T, et al. Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatol Ther. 2021;34(2):e14851. doi:10.1111/dth.14851
Google Scholar
15.
Baker A, Young K, Potter J, Madan I. A review of grading systems for evidence-based guidelines produced by medical specialties. Clinical medicine (London, England). 2010;10(4):358-363. doi:10.7861/clinmedicine.10-4-358
Google Scholar
16.
Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020;28(1):9-13.
Google Scholar
17.
Acharya P, Mathur M. Hidradenitis suppurativa and smoking: a systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2020;82(4):1006-1011. doi:10.1016/j.jaad.2019.10.044
Google Scholar
18.
Sivanand A, Gulliver WP, Josan CK, Alhusayen R, Fleming PJ. Weight Loss and Dietary Interventions for Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg. 2020;24(1):64-72. doi:10.1177/1203475419874412
Google Scholar
19.
Barrea L, Fabbrocini G, Annunziata G, et al. Role of nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients. 2019;11(1):57. doi:10.3390/nu11010057
Google Scholar
20.
Cheng HM, Liu WC, Chua G, et al. Impact of a pharmacy-led smoking cessation clinic in a dermatology centre. Singapore Med J. 2019;60(1):31-33. doi:10.11622/smedj.2018063
Google Scholar
21.
Cannistrà C, Finocchi V, Trivisonno A, Tambasco D. New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer’s yeast-exclusion diet. Surgery. 2013;154(5):1126-1130. doi:10.1016/j.surg.2013.04.018
Google Scholar
22.
Garg A, Hundal J, Strunk A. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States. JAMA Dermatol. 2018;154(7):814-818. doi:10.1001/jamadermatol.2018.0878
Google Scholar
23.
Urquiaga I, Echeverría G, Dussaillant C, Rigotti A. Origin, components and mechanisms of action of the Mediterranean diet. Rev Med Chil. 2017;145(1):85-95. doi:10.4067/s0034-98872017000100012
Google Scholar
24.
Dempsey A, Butt M, Kirby JS. Prevalence and Impact of Dietary Avoidance among Individuals with Hidradenitis Suppurativa. Dermatology. 2020;236(4):289-295. doi:10.1159/000503063
Google Scholar
25.
Fernandez JM, Marr KD, Hendricks AJ, et al. Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther. 2020;33(6):e14246. doi:10.1111/dth.14246
Google Scholar
26.
Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: Implication of the skin-gut axis. Australas J Dermatol. 2019;60(2):e90-e98. doi:10.1111/ajd.12909
Google Scholar
27.
Marasca C, Cinelli E, Annunziata MC, Barrea L, Savastano S, Fabbrocini G. Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa. Dermatology. 2020;236(4):296-297. doi:10.1159/000504912
Google Scholar
28.
Brocard A, Dréno B. Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis. J Eur Acad Dermatol Venereol. 2011;25(10):1146-1152. doi:10.1111/j.1468-3083.2010.03934.x
Google Scholar
29.
Hessam S, Sand M, Meier NM, Gambichler T, Scholl L, Bechara FG. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84(2):197-202. doi:10.1016/j.jdermsci.2016.08.010
Google Scholar
30.
Stashower J, Pollack K, Flowers RH. Severe anemia and copper deficiency in a patient treated with supplemental zinc for hidradenitis suppurativa. Int J Dermatol. Published online 2021. doi:10.1111/ijd.15652
Google Scholar
31.
Kechichian E, Ezzedine K. Vitamin D and the Skin: An Update for Dermatologists. Am J Clin Dermatol. 2018;19(2):223-235. doi:10.1007/s40257-017-0323-8
Google Scholar
32.
Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36(2):361-370. doi:10.1002/eji.200425995
Google Scholar
33.
Guillet A, Brocard A, Bach Ngohou K, et al. Verneuil’s disease, innate immunity and vitamin D: a pilot study. J Eur Acad Dermatol Venereol. 2015;29(7):1347-1353. doi:10.1111/jdv.12857
Google Scholar
34.
Silfvast-Kaiser A, Youssef R, Paek SY. Diet in hidradenitis suppurativa: a review of published and lay literature. Int J Dermatol. 2019;58(11):1225-1230. doi:10.1111/ijd.14465
Google Scholar
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.